European research yields guidelines for treatment of HIV-positive pregnant women and infantsJune 28, 2002New guidelines for the treatment of HIV-positive women and children are emerging from European research. The guidelines, aimed at reducing mother-to-child transmission of HIV, are to be published on 28 June 2002 as a supplement to the journal AIDS. A comparable set of guidelines for paediatric patients will be published in July 2002. Both reports result from concerted action projects funded by the European Commission's DG Research. "The definition of HIV treatment guidelines that will limit the risk of mother-to-child transmission of the virus is a good example of the benefits of collaborating at European scale", said European Commissioner for Research Philippe Busquin. "HIV knows no borders and we need to bring together the best specialists to stem the epidemic and find appropriate treatments." In Western Europe, 560,000 people are living with HIV/AIDS. The number of HIV infected adults continues to increase: 30,000 were infected in 2001 and 25% of those are women. The occurrence of HIV-positive pregnant women is a growing concern and mother-to-child transmission (MTCT) is a critical issue. Although potent and effective anti-retroviral therapy is now available to delay progression of the disease, this needs to be used carefully and appropriately. Fifteen research teams from seven European countries have worked together to define a set of guidelines for best practice. Their report highlights that certain precautions and the appropriate use of anti-retroviral therapy during pregnancy, labour and in the neonatal period can reduce the risk of MTCT from 15-20% (without intervention) to less than 2%. The guidelines include: - recommending that all pregnant women (and if possible their partners) have a HIV test; - offering HIV-infected women the option of delivering their child through a caesarean section (before labour and rupture of membranes), as this has been shown to reduce risk of MTCT; - offering all HIV-infected women anti-retroviral therapy during pregnancy to reduce MTCT, with choice of therapy and timing depending on their clinical status; in fact a great deal of attention is given to the various factors influencing this choice, the possibilities for treatment and the need for informed consent of the patient; - recommending anti-retroviral therapy for the child immediately after birth; - strongly advising HIV-infected mothers against breastfeeding, as the risk of MTCT through breastfeeding is substantial and unnecessary as safe alternatives are available. This valuable work was co-ordinated by Prof. Marie-Louise Newell, co-ordinator of the European Collaborative Study on HIV infection in women and children, University College London (m.newell@ich.ucl.ac.uk). The other experts and contributors are listed in the annex. The full report is available in AIDS (2002) supplement 2, June, 24 pages (http://www.aidsonline.com/). The European Commission is strongly committed to combating AIDS in Europe, through the priority on "combating major diseases" defined in the next European research Framework programme (2002-2006). It is also tackling AIDS in Developing Countries, where it is intricately linked with poverty, through the recently initiated European-Developing Countries Clinical Trials Partnership (EDCTP) which proposes to contribute EUR200 million and trigger collaboration between European and African countries. European Commission, Research Directorate |
|||||||||||||||||||||
| Related AIDS Current Events and AIDS News Articles Global challenges and opportunities in fighting HIV/AIDS and neglected diseases Responding to the HIV/AIDS pandemic and tackling so-called neglected tropical diseases are the focus of the November/December 2009 edition of Health Affairs. Losing your tongue Elder Tommy George has not spoken his aboriginal language of Kuku Thaypan for three years, since his brother died. "It might die in the throat, but it stays alive in the heart," he said to the Queensland Courier-Mail in June, 2009. Placental precursor stem cells require testosterone-free environment to survive Trophoblast stem cells (TSCs), cells found in the layer of peripheral embryonic stem cells from which the placenta is formed, are thought to exhibit "immune privilege" that aids cell survivability and is potentially beneficial for cell and gene therapies. Propolis has proved to be a product with ability to have beneficial effects for health Growing concerns about health has caused the scientific community to focus their interest on investigating functional foods which contribute to boosting the prevention and reduction of the risk of suffering from certain illnesses. Endocrine Society calls for expanded scope and funding for stem cell research Stem cell research holds great promise for the treatment of millions of Americans with debilitating and possibly fatal diseases. Scientists use world's fastest supercomputer to create the largest HIV evolutionary tree Supporting Los Alamos National Laboratory's role in the international Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, researchers are using the Roadrunner supercomputer to analyze vast quantities of genetic sequences from HIV infected people in the hope of zeroing in on possible vaccine target areas. Will genomics help prevent the next pandemic? This week, the Public Library of Science, an open-access publisher, presents the "Genomics of Emerging Infectious Disease," a collection of essays, perspectives, and reviews that explores how genomics-with all its associated tools and techniques-can provide insights into our understanding of emerging infectious disease. 1 shot of gene therapy and children with congenital blindness can now see Born with a retinal disease that made him legally blind, and would eventually leave him totally sightless, the nine-year-old boy used to sit in the back of the classroom, relying on the large print on an electronic screen and assisted by teacher aides. Childhood risk factors for developing substance dependence There is ample evidence for the genetic influence of alcohol dependence, and ongoing studies are actively looking for specific genes that may confer this increased susceptibility. HIV care providers applaud Congress' extension of Ryan White program Medical providers on the front lines of HIV care applaud the U.S. Congress for extending the Ryan White HIV/AIDS Program, helping to ensure that more than half a million low-income, uninsured, or underinsured people living with HIV/AIDS have access to lifesaving care. More AIDS Current Events and AIDS News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||